Goodwin represented Kaleido Biosciences, which announced today that it has closed $101 million in an oversubscribed Series C financing. Several new investors participated in the financing,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
